期刊文献+

52例脊索瘤临床病理学观察

Clinicopathological observation of 52 cases of chordoma
下载PDF
导出
摘要 目的:研究脊索瘤的临床病理特征。方法:对52例脊索瘤患者的临床表现、病理学形态、免疫表型、治疗方法和预后进行回顾性分析。结果:年龄27~79(中位58)岁,其中男29例,女23例。骶尾部46例,蝶鞍部2例,斜坡1例,颈椎2例,腰椎1例。影像学显示溶骨性破坏。形态学瘤细胞呈分叶状结构,富含黏液样基质并可见胞内囊泡,免疫组织化学上皮性标志及S100蛋白阳性表达。1例去分化为纤维肉瘤,且Ki-67增殖指数升高。其中27例(52%)复发,3例转移。结论:脊索瘤多见于中老年人中轴骨,低度恶性,复发常见,可远处转移,病理形态以经典型为主,可发生去分化并提示预后不良。免疫组织化学有助于诊断及鉴别诊断。 Objective: To study the clinicopathologic feature of chordoma. Methods: The clinical data of 52 cases of chordoma were retrospectively analyzed, including clinical features, pathological morphology, immunophenotype,treatment and prognosis. Results: The age ranged from 27–79 years(median age: 58 years), 29 males and 23 females were included. Forty-six cases occurred in the sacrococcygeal, 2 cases in the sella, 1 case in the slope, 2 cases in the cervical spine and 1 case in the lumbar spine. Radiology images showed the osteolytic destruction.Morphologically, the tumor cells were lobulated, rich in mucin-like matrix and had visible intracellular vesicles.Immunohistochemistry showed epithelial markers and S100 protein were positively expressed. One of these cases dedifferentiated into fibrosarcoma, with an increased Ki67 proliferation index. Among these cases, 27(52%) recurred and 3 metastasized. Conclusion: Chordoma is more common in the axial bone of middle-aged and elderly people, with low degree of malignancy, common recurrence, and possibility of metastasis. The main pathological type is classical type, and sometimes it may occur dedifferentiation suggesting poor prognosis.Immunohistochemistry is contribute to diagnosis and differential diagnosis.
作者 马艳英 夏庆欣 孙淼淼 张建波 赵冬梅 MA Yanying;XIA Qjngxin;SUN Miaomiao;ZHANG Jianbo;ZHAO Dongmei(Department of Pathology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Chin)
出处 《临床与病理杂志》 2018年第5期961-965,共5页 Journal of Clinical and Pathological Research
基金 河南省基础与前沿技术研究项目(152300410001)~~
关键词 脊索瘤 免疫组织化学 临床病理学 整合酶相互作用分子1 chordoma immunohistochemistry clinicopathology integrase interactor 1
  • 相关文献

参考文献4

二级参考文献37

  • 1张俊廷,王亮,吴震,贾桂军,张力伟.颅底脊索瘤患者生存因素分析[J].中华医学杂志,2007,87(23):1607-1610. 被引量:7
  • 2McMaster M L, Goldstein A M, Bromley C M, et al. Chordoma: incidence and survival patterns in the United States, 1973-1995 [J]. Cancer Causes Control, 2001 ,12(1 ) :1 - 11.
  • 3Naka T, Iwamoto Y, Shinohara N, et al. Expression of c-met pro- to-oncogene product (c-MET) in benign and malignant bone tumors[J]. Mod Pathol, 1997,10(2) :832 -8.
  • 4Deniz M L, Kilic T, Almaata I, et al. Expression of growth factors and tructural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and flbronectin are correlated with recurrence[J]. Neurosurgery, 2002,51(3) :753 -60.
  • 5Kilgore S, Prayson R A. Apoptotic and proliferative markers in chordomas : a study of 26 tumors [ J ]. Ann Diagn Pathol, 2002,6 (4) :222 -8.
  • 6Laguda B, Selden C, Jones M, et al. Assignment of the hepato- cyte growth factor (HGF) to chromosome 7q22-q[ J]. Ann Hum Genet, 1991,55(3) :213 -6.
  • 7Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more[J]. Nat Rev Mol Cell Biol, 2003,4(12) :915 - 25.
  • 8Rodrigue T, Fragosol L. Physiologic and physiopathologic role of hepatocyte growth factor[ J]. Rev Invest Clin, 1998,50(4) :355 -67.
  • 9Scheil S, Bruederlein S, Liehr T, et al. Genome wide analysis of 16 chordomas by comparative genomic hybridizationand cytogenet- ics of the first human chordoma cell line, U-CH1 [ J ]. Genes Chromosom Cancer, 2001,32(3) :203 -11.
  • 10Weinberger P M, Yu Z, Kowalski D, et al. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chrodoma compared with 17 other malignancies [ J]. Arch Otolar- yngol Head Neck Surg, 2005,131 (8) :707 - 11.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部